Pharmacy Owners, Salaried Pharmacists, and the Capital on the Shelf

A pharmacy looks like a retail business and is not one.

Most of the money is not in the till, and a large part of the revenue was never negotiated with the person standing at the counter. It was set by a payer who has never been in the store.

And a good deal of what looks like an owner's decision belongs to somebody else, because the banner agreement decides more than most owners describe when asked what they own.

Two readers, one page

The first is the owner. A pharmacist who bought or built a pharmacy, carries acquisition debt, holds inventory, employs people, and has a succession problem that arrives whether or not it is planned for.

The second is the employed pharmacist. A strong, stable salary, no business, a household that has never had an income shock, and consequently a household that has never had to think about capital as a separate thing from income.

They are on one page because the underlying question is the same. Who performs the financing function in this life, and who is paid for performing it. The owner meets that question through the business; the employee meets it through a mortgage, a vehicle, an education and a renovation, and never sees it added up.

What a pharmacy actually has money tied up in

Inventory, first and largest. Dispensing stock, front shop stock where there is one, and a small number of expensive specialty products that absorb a disproportionate share of the working capital.

Receivables that are not from customers. A large part of what has been dispensed has not yet been paid, because the payer is a plan rather than a person and payment follows a claims cycle.

The equipment and the fit out. Dispensing automation, cold chain storage, counselling space, a compounding area where the pharmacy does that work, and the security and record keeping that controlled substances require.

And the purchase of the business itself. Most owners bought in or bought out, so acquisition debt is usually still being serviced while everything above is being financed as well.

Inventory, which is capital standing on a shelf

Every unit on the shelf is money that has already left the account. That is true of any retailer, and three things make it sharper here.

It expires. Slow moving stock is not idle capital, it is capital with a deadline, and product that reaches its date is a write off rather than a clearance sale.

Some of it is controlled, and some of it is expensive. Controlled substances carry custody, counting and reporting obligations that ordinary retail does not, and specialty products tie up far more money per unit than a shelf of familiar packages.

And it cannot be discounted out the door. A clothing retailer facing a bad season marks stock down. A pharmacy cannot solve an inventory problem that way, which means the capital committed to the shelf is committed on terms the owner does not fully control.

So the pharmacy finances its inventory, continuously, for as long as it operates. Through a supplier arrangement, an operating line, or its own cash, and whoever supplies that capital is paid for supplying it, every cycle, for the life of the business.

The revenue that is set rather than negotiated

A material part of a pharmacy's income is paid on a schedule. A public drug plan decides what it pays for a listed product and what it pays for the professional act, and those decisions are made through policy rather than across a counter.

That is not a complaint. A public payer negotiating on behalf of a population is doing what it exists to do, and the schedule is published rather than hidden.

What matters for planning is that it is exogenous. It can be revised, and a revision does not arrive as one lost customer. It arrives as a change to the entire revenue line at once, on a date the owner did not choose.

A business whose pricing is decided elsewhere has to manage what it does control. Its costs, its mix, its service model, and its capital. The last of those is the one most owners have never examined, because it does not appear on any statement as a line called capital.

The banner agreement, and what it actually decides

Most Canadian pharmacies operate under a banner or franchise arrangement, and the agreement decides considerably more than the sign.

Depending on the arrangement, it can govern purchasing, supply, branding, fees, systems, renovation obligations and hours. Each is a cost the owner carries and, in several cases, cannot reduce by shopping.

Most consequentially, it can restrict transfer. Who the pharmacy may be sold to, on what conditions, and whether somebody else has a right to buy first. An owner who assumes an open market and discovers otherwise has learned it during a sale, which is the expensive time to learn it.

None of that is an insurance question and none of it is answered here. It is answered by a lawyer who has read that specific agreement, and the reason it appears on this page is that it constrains every other plan an owner makes.

Infinite Financial Sovereignty®, and whose idea the underlying one was

The underlying idea is not this practice's. The method Nelson Nash named The Infinite Banking Concept® is a mark of Infinite Banking Concepts, LLC, described in his own writing, and neither Canadian Wealth Creation Centre Inc. nor Jose Salloum is affiliated with that organisation or endorsed by it.

Infinite Financial Sovereignty® is this practice's own registered mark, and it names one narrower discipline carried out over a lifetime: that a business should be its own source of capital for the purchases it makes repeatedly.

In practice it means holding capital inside a participating whole life contract issued by a federally regulated insurer. The contract accumulates a contractual value. When capital is needed, an advance is taken against the contract rather than arranged with an outside lender, and it is repaid on a schedule the owner sets.

None of this is free, fast, or a way of avoiding interest. The insurer charges interest on an advance, the costs of the contract fall heaviest in the early years, and what changes is the destination of the financing margin rather than its existence.

What capital under the owner's control changes

Not the reimbursement schedule, and not the banner agreement. Neither of those moves because a pharmacy has capital, and any presentation implying otherwise is describing a different business.

What it changes is the response to both. A store that has to refit, upgrade cold chain storage, replace dispensing automation or fund a larger inventory position has somewhere to go that is not an application.

And it changes the timing of the worst conversations. Capital already under the owner's control does not have to be applied for in the quarter a business would least like to be applying for anything.

The repayment is the part that matters and the part most often skipped. An owner who takes an advance and does not repay it has not performed the financing function, only relocated it. The discipline is the strategy; the contract is merely where the capital sits.

And the death benefit is doing its own job throughout. This is life insurance, and for an owner with acquisition debt, a lease, staff and a family, what it pays on death is not a secondary consideration.

The corporation, and who may hold the shares

Most owners in a position to consider this are incorporated, so the ownership question arrives immediately.

Three decisions have to be made together: who owns the contract, who pays the premium, and who is named as beneficiary. Deciding them separately, or leaving them to whoever fills in the application, is the commonest expensive error in this area and it is set out at length under corporate-owned life insurance.

Pharmacy ownership rules are provincial and they are not uniform. What a pharmacy corporation may do, who may hold its shares, and whether a person who is not a pharmacist may hold any interest all differ, and they interact with the banner agreement rather than sitting beside it.

A mismatch does not announce itself. Where one entity pays a premium and another is advantaged, a taxable benefit can arise for whoever was advantaged, and it is typically discovered years later on an audit or during a sale.

What the tax treatment depends on

On facts about the particular corporation, confirmed with your own accountant before anything is applied for. That is the load-bearing condition of everything above rather than a disclaimer beneath it.

Premiums are generally not deductible, with a narrow exception where a policy is assigned as collateral for a loan used to earn income, subject to conditions that must be met rather than assumed.

Growth inside the contract is not taxed annually while the contract remains exempt under Regulation 306, Income Tax Regulations. Exempt status is maintained rather than inherent, and a contract altered carelessly later can fail it.

On death, the amount by which the benefit exceeds the policy's adjusted cost basis is credited to the Capital Dividend Account under ITA s.89(1), from which a capital dividend may be elected. The credit is the excess rather than the whole benefit, the adjusted cost basis moves over the life of the contract, and the election is a filing. Your accountant calculates it.

The salaried pharmacist, who is a different reader

No business, no inventory, no banner, and a strong income that arrives on the same day every two weeks. That last fact is the whole of the difference, and it cuts both ways.

A household whose income has never wobbled plans around income. The budget is built from the paycheque, the large purchases are financed externally as they arise, and nobody has ever asked what the financing across a working life costs in total.

The purchases are the same ones every household makes. A home, vehicles, a renovation, an education, and the years supporting both children and a parent. Each is financed by somebody, and whoever performs that function is paid for it.

The first questions are not about capital at all. Whether coverage is adequate and portable, whether disability protection exists and on what definition, and whether the beneficiary designations on every policy including the group plan still name the people intended.

Only after those does the capital question arise. Nothing on this page argues for a particular order between registered accounts and a contract, in either direction. That sequence should be decided on your own figures with an accountant rather than recited, and the part usually left unexamined is where the money funding any of it comes from.

Why a stable income hides the question

Because nothing ever forces the household to look. A business with a bad quarter examines its capital position because it has to. A household with a dependable salary can go thirty years without ever asking where its financing margin went.

And because employment feels like the safe version. It is safer in one specific way, that the income does not fluctuate, and no safer against disability, a store closing, or a reorganisation that consolidates positions.

The employed pharmacist also holds a licence rather than an asset. Earning capacity is the whole of the household's balance sheet in the early years, which is why protecting it comes before anything else on this page.

What this does not do

It does not eliminate interest. The insurer charges interest on an advance, and a presentation that omits that has misdescribed the arrangement.

It does not reduce a personal tax bill. Nothing here is a deduction, and any suggestion that a premium is a way of paying less tax this year is wrong.

It does not replace an operating line or a supplier arrangement. A pharmacy should keep committed external credit for payroll timing, for a claims cycle that runs late, and for an emergency that outruns any accumulated capital.

It does not outperform a market portfolio measured as a return, and an owner shopping on rate of return will be disappointed by an honest comparison. Participating whole life insurance is an insurance product and not an investment, which is a difference in purpose rather than in marketing.

And it does not survive being started and abandoned. A contract surrendered early returns less than was paid into it, permanently.

Who this does not suit

A pharmacy without durable surplus in a normal year, as distinct from a strong one. Surplus that appears only in the strongest of the last several years is not the raw material this requires.

An owner who may need the money back within a few years. Early exit is a loss rather than a delay, and no design changes that.

An owner carrying heavy acquisition or inventory debt at a high rate. Repaying it is usually the better use of the same dollar, and saying so costs this practice a sale it would otherwise have made.

An owner within about a decade of leaving. The early costs will not have been recovered and the compounding has no time to work.

A salaried pharmacist without adequate disability coverage, because earning capacity is the asset every other arrangement assumes will continue.

And anyone whose accountant has not seen the structure. A structure nobody has checked is the one that surfaces on an audit.

What stands behind the contract

The contractual obligations of the issuing insurer, and nothing else. They depend on that insurer's continued solvency and they are not backed by any government, which is a materially different position from a deposit at a chartered bank.

Assuris protects Canadian policyholders within its published limits where an insurer fails. That is meaningful and it is not the same thing as deposit protection.

Dividends are not guaranteed. They are declared annually at the discretion of the insurer's board based on the performance of the participating account, and past dividend performance does not indicate future results. The guaranteed schedule and the projected values above it are two different columns on the same page.

The order to do it in

Find out how much capital is standing in inventory and receivables rather than in the account. The figure is in the system already and almost nobody has looked at it as a capital question rather than an operations one.

Then add up what has been paid to finance it. Supplier terms, the operating line, and the acquisition debt, across the years the pharmacy has been owned.

Then take both to your accountant, before any insurance conversation. The questions are whether the corporation is the right owner, what the position looks like between active and investment income, and whether the shares are intended to be sold one day.

Then, and only then, look at whether a contract belongs in the picture. Purpose first, structure second, product last. Reversing that order is common precisely because only the last step pays a commission.

Three of those four steps cost nothing and earn nobody anything, which is worth knowing about the order in which they are usually proposed.

Who you are dealing with

IBC Financial is the education platform and trade name of Canadian Wealth Creation Centre Inc. Every client relationship, every piece of advice and every insurance product comes through Canadian Wealth Creation Centre Inc. and its duly certified representatives, and this page is education rather than advice about any particular pharmacy or household.

Everything here is written by somebody paid a commission by an insurer when a contract is issued, which is stated at the foot of every page on this site and is a reason to check the arithmetic rather than to accept it.

The corporate structuring sits under business owners, the mechanism of the contract itself is in how a participating policy works, the treatment of an advance is under policy loans, and the sequence for an owner who will one day leave is in the succession process.